Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study
Napapon Sailasuta, Kent Harris, Thao Tran, Brian RossClinical MR Unit, Huntington Medical Research Institutes, Pasadena, CA, USAAbstract: We applied 13C magnetic resonance spectroscopy (MRS), a nonradioactive, noninvasive brain imaging technique, to quantify the oxidation of [1-13C] acetate in a con...
Saved in:
Main Authors: | Tran T, Harris K, Sailasuta N, Ross B |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/5ba6dcdf4ac942c3afd7e47b352ab4ae |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands
by: Hoogveldt B, et al.
Published: (2011) -
Alzheimer's disease and blood-based biomarkers – potential contexts of use
by: Zvěřová M
Published: (2018) -
Editor's choice
by: Pinder RM
Published: (2012) -
Present and prospective clinical therapeutic regimens for Alzheimer’s disease
by: Mustafa M Husain, et al.
Published: (2008) -
Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting
by: Wallin ÅK, et al.
Published: (2011)